Your browser doesn't support javascript.
loading
Single-cell profiling reveals age-associated immunity in atherosclerosis.
Smit, Virginia; de Mol, Jill; Schaftenaar, Frank H; Depuydt, Marie A C; Postel, Rimke J; Smeets, Diede; Verheijen, Fenne W M; Bogers, Laurens; van Duijn, Janine; Verwilligen, Robin A F; Grievink, Hendrika W; Bernabé Kleijn, Mireia N A; van Ingen, Eva; de Jong, Maaike J M; Goncalves, Lauren; Peeters, Judith A H M; Smeets, Harm J; Wezel, Anouk; Polansky, Julia K; de Winther, Menno P J; Binder, Christoph J; Tsiantoulas, Dimitrios; Bot, Ilze; Kuiper, Johan; Foks, Amanda C.
Afiliación
  • Smit V; Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • de Mol J; Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Schaftenaar FH; Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Depuydt MAC; Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Postel RJ; Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Smeets D; Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Verheijen FWM; Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Bogers L; Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • van Duijn J; Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Verwilligen RAF; Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Grievink HW; Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Bernabé Kleijn MNA; Centre for Human Drug Research, Zernikedreef 8, 2333 CL Leiden, The Netherlands.
  • van Ingen E; Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • de Jong MJM; Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Goncalves L; Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Peeters JAHM; Department of Surgery, Haaglanden Medical Center-location Westeinde, Lijnbaan 32, 2515 VA The Hague, The Netherlands.
  • Smeets HJ; Department of Surgery, Haaglanden Medical Center-location Westeinde, Lijnbaan 32, 2515 VA The Hague, The Netherlands.
  • Wezel A; Department of Surgery, Haaglanden Medical Center-location Westeinde, Lijnbaan 32, 2515 VA The Hague, The Netherlands.
  • Polansky JK; Department of Surgery, Haaglanden Medical Center-location Westeinde, Lijnbaan 32, 2515 VA The Hague, The Netherlands.
  • de Winther MPJ; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Augustenburger Platz 1, 13353 Berlin, Germany.
  • Binder CJ; Amsterdam University Medical Centers-location AMC, University of Amsterdam, Experimental Vascular Biology, Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Tsiantoulas D; Department of Laboratory Medicine, Medical University of Vienna, Lazarettgasse 14, AKH BT25.2, 1090 Vienna, Austria.
  • Bot I; Department of Laboratory Medicine, Medical University of Vienna, Lazarettgasse 14, AKH BT25.2, 1090 Vienna, Austria.
  • Kuiper J; Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Foks AC; Leiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
Cardiovasc Res ; 119(15): 2508-2521, 2023 11 25.
Article en En | MEDLINE | ID: mdl-37390467
ABSTRACT

AIMS:

Aging is a dominant driver of atherosclerosis and induces a series of immunological alterations, called immunosenescence. Given the demographic shift towards elderly, elucidating the unknown impact of aging on the immunological landscape in atherosclerosis is highly relevant. While the young Western diet-fed Ldlr-deficient (Ldlr-/-) mouse is a widely used model to study atherosclerosis, it does not reflect the gradual plaque progression in the context of an aging immune system as occurs in humans. METHODS AND

RESULTS:

Here, we show that aging promotes advanced atherosclerosis in chow diet-fed Ldlr-/- mice, with increased incidence of calcification and cholesterol crystals. We observed systemic immunosenescence, including myeloid skewing and T-cells with more extreme effector phenotypes. Using a combination of single-cell RNA-sequencing and flow cytometry on aortic leucocytes of young vs. aged Ldlr-/- mice, we show age-related shifts in expression of genes involved in atherogenic processes, such as cellular activation and cytokine production. We identified age-associated cells with pro-inflammatory features, including GzmK+CD8+ T-cells and previously in atherosclerosis undefined CD11b+CD11c+T-bet+ age-associated B-cells (ABCs). ABCs of Ldlr-/- mice showed high expression of genes involved in plasma cell differentiation, co-stimulation, and antigen presentation. In vitro studies supported that ABCs are highly potent antigen-presenting cells. In cardiovascular disease patients, we confirmed the presence of these age-associated T- and B-cells in atherosclerotic plaques and blood.

CONCLUSIONS:

Collectively, we are the first to provide comprehensive profiling of aged immunity in atherosclerotic mice and reveal the emergence of age-associated T- and B-cells in the atherosclerotic aorta. Further research into age-associated immunity may contribute to novel diagnostic and therapeutic tools to combat cardiovascular disease.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades de la Aorta / Enfermedades Cardiovasculares / Aterosclerosis / Placa Aterosclerótica Tipo de estudio: Risk_factors_studies Límite: Aged / Animals / Humans Idioma: En Revista: Cardiovasc Res Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades de la Aorta / Enfermedades Cardiovasculares / Aterosclerosis / Placa Aterosclerótica Tipo de estudio: Risk_factors_studies Límite: Aged / Animals / Humans Idioma: En Revista: Cardiovasc Res Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos
...